img

Global Sevelamer Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sevelamer Market Insights, Forecast to 2034

Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
Global Sevelamer market is expected to reach to US$ 235 million in 2024, with a positive growth of %, compared with US$ 220 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Sevelamer industry is evaluated to reach US$ 337.1 million in 2029. The CAGR will be 6.2% during 2024 to 2029.
Globally, Sevelamer key manufacturers include Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma and Amneal Pharmaceuticals, etc. Sanofi, Impax Laboratories, InvaGen Pharmaceuticals are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Sevelamer were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Sevelamer market and estimated to attract more attentions from industry insiders and investors.
Sevelamer can be divided into Tablet and Oral Suspension, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Sevelamer is widely used in various fields, such as Adult and Pediatric, etc. Adult provides greatest supports to the Sevelamer industry development. In 2022, global % sales of Sevelamer went into Adult filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Sevelamer market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sevelamer market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
Segment by Type
Tablet
Oral Suspension

Segment by Application


Adult
Pediatric

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sevelamer plant distribution, commercial date of Sevelamer, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sevelamer introduction, etc. Sevelamer Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Sevelamer
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Sevelamer Product Introduction
1.2 Market by Type
1.2.1 Global Sevelamer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Sevelamer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Pediatric
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sevelamer Sales Estimates and Forecasts 2018-2029
2.2 Global Sevelamer Revenue by Region
2.2.1 Global Sevelamer Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Sevelamer Revenue by Region (2018-2024)
2.2.3 Global Sevelamer Revenue by Region (2024-2029)
2.2.4 Global Sevelamer Revenue Market Share by Region (2018-2029)
2.3 Global Sevelamer Sales Estimates and Forecasts 2018-2029
2.4 Global Sevelamer Sales by Region
2.4.1 Global Sevelamer Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Sevelamer Sales by Region (2018-2024)
2.4.3 Global Sevelamer Sales by Region (2024-2029)
2.4.4 Global Sevelamer Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Sevelamer Sales by Manufacturers
3.1.1 Global Sevelamer Sales by Manufacturers (2018-2024)
3.1.2 Global Sevelamer Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sevelamer in 2022
3.2 Global Sevelamer Revenue by Manufacturers
3.2.1 Global Sevelamer Revenue by Manufacturers (2018-2024)
3.2.2 Global Sevelamer Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Sevelamer Revenue in 2022
3.3 Global Key Players of Sevelamer, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Sevelamer Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Sevelamer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Sevelamer, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Sevelamer, Product Offered and Application
3.8 Global Key Manufacturers of Sevelamer, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sevelamer Sales by Type
4.1.1 Global Sevelamer Historical Sales by Type (2018-2024)
4.1.2 Global Sevelamer Forecasted Sales by Type (2024-2029)
4.1.3 Global Sevelamer Sales Market Share by Type (2018-2029)
4.2 Global Sevelamer Revenue by Type
4.2.1 Global Sevelamer Historical Revenue by Type (2018-2024)
4.2.2 Global Sevelamer Forecasted Revenue by Type (2024-2029)
4.2.3 Global Sevelamer Revenue Market Share by Type (2018-2029)
4.3 Global Sevelamer Price by Type
4.3.1 Global Sevelamer Price by Type (2018-2024)
4.3.2 Global Sevelamer Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Sevelamer Sales by Application
5.1.1 Global Sevelamer Historical Sales by Application (2018-2024)
5.1.2 Global Sevelamer Forecasted Sales by Application (2024-2029)
5.1.3 Global Sevelamer Sales Market Share by Application (2018-2029)
5.2 Global Sevelamer Revenue by Application
5.2.1 Global Sevelamer Historical Revenue by Application (2018-2024)
5.2.2 Global Sevelamer Forecasted Revenue by Application (2024-2029)
5.2.3 Global Sevelamer Revenue Market Share by Application (2018-2029)
5.3 Global Sevelamer Price by Application
5.3.1 Global Sevelamer Price by Application (2018-2024)
5.3.2 Global Sevelamer Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Sevelamer Market Size by Type
6.1.1 US & Canada Sevelamer Sales by Type (2018-2029)
6.1.2 US & Canada Sevelamer Revenue by Type (2018-2029)
6.2 US & Canada Sevelamer Market Size by Application
6.2.1 US & Canada Sevelamer Sales by Application (2018-2029)
6.2.2 US & Canada Sevelamer Revenue by Application (2018-2029)
6.3 US & Canada Sevelamer Market Size by Country
6.3.1 US & Canada Sevelamer Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Sevelamer Sales by Country (2018-2029)
6.3.3 US & Canada Sevelamer Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Sevelamer Market Size by Type
7.1.1 Europe Sevelamer Sales by Type (2018-2029)
7.1.2 Europe Sevelamer Revenue by Type (2018-2029)
7.2 Europe Sevelamer Market Size by Application
7.2.1 Europe Sevelamer Sales by Application (2018-2029)
7.2.2 Europe Sevelamer Revenue by Application (2018-2029)
7.3 Europe Sevelamer Market Size by Country
7.3.1 Europe Sevelamer Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Sevelamer Sales by Country (2018-2029)
7.3.3 Europe Sevelamer Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Sevelamer Market Size
8.1.1 China Sevelamer Sales (2018-2029)
8.1.2 China Sevelamer Revenue (2018-2029)
8.2 China Sevelamer Market Size by Application
8.2.1 China Sevelamer Sales by Application (2018-2029)
8.2.2 China Sevelamer Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sevelamer Market Size by Type
9.1.1 Asia Sevelamer Sales by Type (2018-2029)
9.1.2 Asia Sevelamer Revenue by Type (2018-2029)
9.2 Asia Sevelamer Market Size by Application
9.2.1 Asia Sevelamer Sales by Application (2018-2029)
9.2.2 Asia Sevelamer Revenue by Application (2018-2029)
9.3 Asia Sevelamer Sales by Region
9.3.1 Asia Sevelamer Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Sevelamer Revenue by Region (2018-2029)
9.3.3 Asia Sevelamer Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Sevelamer Market Size by Type
10.1.1 Middle East, Africa and Latin America Sevelamer Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Sevelamer Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Sevelamer Market Size by Application
10.2.1 Middle East, Africa and Latin America Sevelamer Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Sevelamer Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Sevelamer Sales by Country
10.3.1 Middle East, Africa and Latin America Sevelamer Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Sevelamer Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Sevelamer Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Sevelamer Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Impax Laboratories
11.2.1 Impax Laboratories Company Information
11.2.2 Impax Laboratories Overview
11.2.3 Impax Laboratories Sevelamer Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Impax Laboratories Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Impax Laboratories Recent Developments
11.3 InvaGen Pharmaceuticals
11.3.1 InvaGen Pharmaceuticals Company Information
11.3.2 InvaGen Pharmaceuticals Overview
11.3.3 InvaGen Pharmaceuticals Sevelamer Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 InvaGen Pharmaceuticals Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 InvaGen Pharmaceuticals Recent Developments
11.4 Dr. Reddy's Laboratories
11.4.1 Dr. Reddy's Laboratories Company Information
11.4.2 Dr. Reddy's Laboratories Overview
11.4.3 Dr. Reddy's Laboratories Sevelamer Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Dr. Reddy's Laboratories Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dr. Reddy's Laboratories Recent Developments
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Information
11.5.2 Aurobindo Pharma Overview
11.5.3 Aurobindo Pharma Sevelamer Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Aurobindo Pharma Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aurobindo Pharma Recent Developments
11.6 Amneal Pharmaceuticals
11.6.1 Amneal Pharmaceuticals Company Information
11.6.2 Amneal Pharmaceuticals Overview
11.6.3 Amneal Pharmaceuticals Sevelamer Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Amneal Pharmaceuticals Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amneal Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sevelamer Industry Chain Analysis
12.2 Sevelamer Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sevelamer Production Mode & Process
12.4 Sevelamer Sales and Marketing
12.4.1 Sevelamer Sales Channels
12.4.2 Sevelamer Distributors
12.5 Sevelamer Customers
13 Market Dynamics
13.1 Sevelamer Industry Trends
13.2 Sevelamer Market Drivers
13.3 Sevelamer Market Challenges
13.4 Sevelamer Market Restraints
14 Key Findings in The Global Sevelamer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sevelamer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Oral Suspension
Table 4. Global Sevelamer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Sevelamer Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Sevelamer Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Sevelamer Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Sevelamer Revenue Market Share by Region (2018-2024)
Table 9. Global Sevelamer Revenue Market Share by Region (2024-2029)
Table 10. Global Sevelamer Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Sevelamer Sales by Region (2018-2024) & (K Units)
Table 12. Global Sevelamer Sales by Region (2024-2029) & (K Units)
Table 13. Global Sevelamer Sales Market Share by Region (2018-2024)
Table 14. Global Sevelamer Sales Market Share by Region (2024-2029)
Table 15. Global Sevelamer Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Sevelamer Sales Share by Manufacturers (2018-2024)
Table 17. Global Sevelamer Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Sevelamer Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Sevelamer, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Sevelamer Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Sevelamer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Sevelamer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sevelamer as of 2022)
Table 23. Global Key Manufacturers of Sevelamer, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Sevelamer, Product Offered and Application
Table 25. Global Key Manufacturers of Sevelamer, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sevelamer Sales by Type (2018-2024) & (K Units)
Table 28. Global Sevelamer Sales by Type (2024-2029) & (K Units)
Table 29. Global Sevelamer Sales Share by Type (2018-2024)
Table 30. Global Sevelamer Sales Share by Type (2024-2029)
Table 31. Global Sevelamer Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Sevelamer Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Sevelamer Revenue Share by Type (2018-2024)
Table 34. Global Sevelamer Revenue Share by Type (2024-2029)
Table 35. Sevelamer Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Sevelamer Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Sevelamer Sales by Application (2018-2024) & (K Units)
Table 38. Global Sevelamer Sales by Application (2024-2029) & (K Units)
Table 39. Global Sevelamer Sales Share by Application (2018-2024)
Table 40. Global Sevelamer Sales Share by Application (2024-2029)
Table 41. Global Sevelamer Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Sevelamer Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Sevelamer Revenue Share by Application (2018-2024)
Table 44. Global Sevelamer Revenue Share by Application (2024-2029)
Table 45. Sevelamer Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Sevelamer Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Sevelamer Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Sevelamer Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Sevelamer Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Sevelamer Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Sevelamer Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Sevelamer Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Sevelamer Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Sevelamer Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Sevelamer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Sevelamer Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Sevelamer Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Sevelamer Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Sevelamer Sales by Country (2024-2029) & (K Units)
Table 60. Europe Sevelamer Sales by Type (2018-2024) & (K Units)
Table 61. Europe Sevelamer Sales by Type (2024-2029) & (K Units)
Table 62. Europe Sevelamer Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Sevelamer Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Sevelamer Sales by Application (2018-2024) & (K Units)
Table 65. Europe Sevelamer Sales by Application (2024-2029) & (K Units)
Table 66. Europe Sevelamer Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Sevelamer Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Sevelamer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Sevelamer Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Sevelamer Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Sevelamer Sales by Country (2018-2024) & (K Units)
Table 72. Europe Sevelamer Sales by Country (2024-2029) & (K Units)
Table 73. China Sevelamer Sales by Type (2018-2024) & (K Units)
Table 74. China Sevelamer Sales by Type (2024-2029) & (K Units)
Table 75. China Sevelamer Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Sevelamer Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Sevelamer Sales by Application (2018-2024) & (K Units)
Table 78. China Sevelamer Sales by Application (2024-2029) & (K Units)
Table 79. China Sevelamer Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Sevelamer Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Sevelamer Sales by Type (2018-2024) & (K Units)
Table 82. Asia Sevelamer Sales by Type (2024-2029) & (K Units)
Table 83. Asia Sevelamer Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Sevelamer Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Sevelamer Sales by Application (2018-2024) & (K Units)
Table 86. Asia Sevelamer Sales by Application (2024-2029) & (K Units)
Table 87. Asia Sevelamer Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Sevelamer Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Sevelamer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Sevelamer Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Sevelamer Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Sevelamer Sales by Region (2018-2024) & (K Units)
Table 93. Asia Sevelamer Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Sevelamer Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Sevelamer Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Sevelamer Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Sevelamer Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Sevelamer Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Sevelamer Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Sevelamer Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Sevelamer Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Sevelamer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Sevelamer Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Sevelamer Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Sevelamer Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Sevelamer Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Sevelamer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. Impax Laboratories Company Information
Table 113. Impax Laboratories Description and Major Businesses
Table 114. Impax Laboratories Sevelamer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Impax Laboratories Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Impax Laboratories Recent Developments
Table 117. InvaGen Pharmaceuticals Company Information
Table 118. InvaGen Pharmaceuticals Description and Major Businesses
Table 119. InvaGen Pharmaceuticals Sevelamer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. InvaGen Pharmaceuticals Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. InvaGen Pharmaceuticals Recent Developments
Table 122. Dr. Reddy's Laboratories Company Information
Table 123. Dr. Reddy's Laboratories Description and Major Businesses
Table 124. Dr. Reddy's Laboratories Sevelamer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Dr. Reddy's Laboratories Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Dr. Reddy's Laboratories Recent Developments
Table 127. Aurobindo Pharma Company Information
Table 128. Aurobindo Pharma Description and Major Businesses
Table 129. Aurobindo Pharma Sevelamer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Aurobindo Pharma Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Aurobindo Pharma Recent Developments
Table 132. Amneal Pharmaceuticals Company Information
Table 133. Amneal Pharmaceuticals Description and Major Businesses
Table 134. Amneal Pharmaceuticals Sevelamer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Amneal Pharmaceuticals Sevelamer Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Amneal Pharmaceuticals Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Sevelamer Distributors List
Table 140. Sevelamer Customers List
Table 141. Sevelamer Market Trends
Table 142. Sevelamer Market Drivers
Table 143. Sevelamer Market Challenges
Table 144. Sevelamer Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Sevelamer Product Picture
Figure 2. Global Sevelamer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Sevelamer Market Share by Type in 2022 & 2029
Figure 4. Tablet Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Sevelamer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Sevelamer Market Share by Application in 2022 & 2029
Figure 8. Adult
Figure 9. Pediatric
Figure 10. Sevelamer Report Years Considered
Figure 11. Global Sevelamer Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Sevelamer Revenue 2018-2029 (US$ Million)
Figure 13. Global Sevelamer Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Sevelamer Revenue Market Share by Region (2018-2029)
Figure 15. Global Sevelamer Sales 2018-2029 ((K Units)
Figure 16. Global Sevelamer Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Sevelamer Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Sevelamer Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Sevelamer Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Sevelamer Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Sevelamer Sales YoY (2018-2029) & (K Units)
Figure 22. China Sevelamer Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Sevelamer Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Sevelamer Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Sevelamer Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Sevelamer Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Sevelamer Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Sevelamer in the World: Market Share by Sevelamer Revenue in 2022
Figure 29. Global Sevelamer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Sevelamer Sales Market Share by Type (2018-2029)
Figure 31. Global Sevelamer Revenue Market Share by Type (2018-2029)
Figure 32. Global Sevelamer Sales Market Share by Application (2018-2029)
Figure 33. Global Sevelamer Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Sevelamer Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Sevelamer Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Sevelamer Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Sevelamer Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Sevelamer Revenue Share by Country (2018-2029)
Figure 39. US & Canada Sevelamer Sales Share by Country (2018-2029)
Figure 40. U.S. Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Sevelamer Sales Market Share by Type (2018-2029)
Figure 43. Europe Sevelamer Revenue Market Share by Type (2018-2029)
Figure 44. Europe Sevelamer Sales Market Share by Application (2018-2029)
Figure 45. Europe Sevelamer Revenue Market Share by Application (2018-2029)
Figure 46. Europe Sevelamer Revenue Share by Country (2018-2029)
Figure 47. Europe Sevelamer Sales Share by Country (2018-2029)
Figure 48. Germany Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 49. France Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 53. China Sevelamer Sales Market Share by Type (2018-2029)
Figure 54. China Sevelamer Revenue Market Share by Type (2018-2029)
Figure 55. China Sevelamer Sales Market Share by Application (2018-2029)
Figure 56. China Sevelamer Revenue Market Share by Application (2018-2029)
Figure 57. Asia Sevelamer Sales Market Share by Type (2018-2029)
Figure 58. Asia Sevelamer Revenue Market Share by Type (2018-2029)
Figure 59. Asia Sevelamer Sales Market Share by Application (2018-2029)
Figure 60. Asia Sevelamer Revenue Market Share by Application (2018-2029)
Figure 61. Asia Sevelamer Revenue Share by Region (2018-2029)
Figure 62. Asia Sevelamer Sales Share by Region (2018-2029)
Figure 63. Japan Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 67. India Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Sevelamer Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Sevelamer Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Sevelamer Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Sevelamer Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Sevelamer Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Sevelamer Sales Share by Country (2018-2029)
Figure 74. Brazil Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Sevelamer Revenue (2018-2029) & (US$ Million)
Figure 79. Sevelamer Value Chain
Figure 80. Sevelamer Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries